Valuation: Astellas Pharma Inc.

Market Cap 3,848B 23.69B 20.71B 19.15B 17.59B 33.26B 2,282B 33.88B 227B 89.43B 1,116B 88.96B 87.03B P/E 2027 *
11.2x
P/E 2028 * 11.7x
Enterprise Value 3,704B 22.8B 19.93B 18.43B 16.94B 32.01B 2,197B 32.61B 218B 86.09B 1,075B 85.64B 83.78B EV / Sales 2027 *
1.64x
EV / Sales 2028 * 1.62x
Free-Float
97.66%
Yield 2027 *
3.75%
Yield 2028 * 3.86%
1 day+0.28%
1 week+0.07%
Current month-1.24%
1 month-0.21%
3 months-17.56%
6 months-6.69%
Current year+2.63%
1 week 2,109
Extreme 2109
2,176
1 month 2,105
Extreme 2105
2,216.5
Current year 2,041
Extreme 2041
2,717
1 year 1,422.5
Extreme 1422.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 09/02/2023
Director of Finance/CFO 54 31/10/2023
Compliance Officer - 31/03/2025
Director TitleAgeSince
Chairman 66 09/02/2023
Director/Board Member 63 31/05/2019
Director/Board Member 58 31/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+0.07%+48.96%+7.13% 23.67B
+1.08%-3.84%+51.50%+160.13% 1,031B
+1.19%-5.10%+61.09%+56.36% 595B
+4.21%+0.65%+36.48%+87.04% 431B
+0.42%-0.99%+30.04%+22.27% 326B
+1.03%-2.10%+28.32%+45.08% 277B
+0.49%-11.32%+20.31%+22.32% 263B
+1.59%+3.91%-22.47%-36.84% 224B
+3.70%+0.98%+27.03%+63.38% 193B
+3.49%+0.35%+24.98%+76.58% 164B
Average +1.75%-3.43%+30.62%+50.34% 352.8B
Weighted average by Cap. +1.65%-4.28%+37.87%+78.95%

Financials

2027 *2028 *
Net sales 2,258B 13.9B 12.15B 11.24B 10.32B 19.51B 1,339B 19.88B 133B 52.47B 655B 52.2B 51.07B 2,074B 12.77B 11.16B 10.32B 9.48B 17.93B 1,230B 18.26B 122B 48.21B 602B 47.95B 46.91B
Net income 345B 2.12B 1.85B 1.71B 1.58B 2.98B 204B 3.03B 20.29B 8.01B 99.94B 7.97B 7.79B 328B 2.02B 1.77B 1.63B 1.5B 2.84B 195B 2.89B 19.32B 7.63B 95.19B 7.59B 7.42B
Net Debt -144B -886M -774M -716M -658M -1.24B -85.34B -1.27B -8.47B -3.34B -41.74B -3.33B -3.25B -478B -2.94B -2.57B -2.38B -2.18B -4.13B -283B -4.21B -28.13B -11.1B -139B -11.04B -10.8B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
16/07/26 JP¥2,148.00 +0.28% 7,147,600
15/07/26 JP¥2,142.00 -0.19% 6,310,600
14/07/26 JP¥2,146.00 +1.18% 5,802,100
13/07/26 JP¥2,121.00 -0.98% 4,304,400
10/07/26 JP¥2,142.00 +0.21% 5,971,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,148.00JPY
Average target price
2,388.46JPY
Spread / Average Target
+11.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock